
1.62BUSD

See which Billionaires own this investment
Type
Common Stock
Exchange
NASDAQ
Currency Code
USD
Currency Name
US Dollar
Country Name
USA
Country ISO
US
ISIN
-
CUSIP
-
Sector
Healthcare
Industry
Biotechnology
Fiscal Year End
December
IPO date
-
Updated At
-
PE Ratio
-
PEG Ratio
-
Book Value
3.13
Dividend Share
-
Dividend Yield
-
Earnings Share
-9.59
Wall Street Target Price
47.88
EPS Estimate Current Year
-5.94
EPS Estimate Next Year
-4.82
EPS Estimate Current Quarter
-1.27
EPS Estimate Next Quarter
-1.28
Most Recent Quarter
-
Revenue TTM
11,000,000
Gross Profit TTM
-226,546,000
EBITDA
-293,305,984
Profit Margin
0.00%
Return On Assets TTM
-36.77%
Return On Equity TTM
-265.11%
Revenue Per Share TTM
0.185
Qtly Revenue Growth YOY
-100.00%
Diluted Eps TTM
-9.59
Qtly Earnings Growth YOY
0.00%
Trailing PE
0.00
Forward PE
0
Price Sales TTM
147.0413
Price Book MRQ
7.5706
Enterprise Value Revenue
115
Enterprise Value EBITDA
0
965.00
0.00%128.26
0.00%390.94
-2.36%151.52
-2.31%925.70
-1.93%32.39
-1.88%318.32
-1.17%516.11
-1.04%917.00
-0.91%199.30
-0.11%